Abstract:Osteoporosis is a disease characterized by decreased bone strength, decreased bone mass, and bone deterioration. The proliferation and osteogenic capacity of osteoblastic cells needs to be improved, for their use in cell-based therapy, and in the treatment of osteoporosis. Taraxasterol, the main constituent of the traditional Chinese medicinal herb Taraxacum, has been demonstrated to have anti-inflammatory, cholesterol-lowering, antirheumatic, anti-cancer, and protective effects. However, the protective effects of taraxasterol, on osteoblastic cells and osteogenic differentiation, have not been reported. Based on the hypothesis that taraxasterol may have an effect on osteoblastic cell growth and differentiation, we studied the effect of taraxasterol on rat osteoblastic cells by detecting cell proliferation, alkaline phosphatase (ALP) activity, and the expression of relevant osteogenic markers. Various concentrations of taraxasterol (0 mu M, 6.25 mu M, 12.5 mu M, and 25 mu M) were used for treatment of rat osteoblastic cells, with the cell proliferation to be detected. Bone morphogenetic protein-2 (BMP-2), runt-related transcription factor 2 (RUNX2), alkaline phosphatase (ALP), bone sialoprotein (BSP), type I collagen (COL-I), and osteocalcin (OCN) expression levels were evaluated by reverse transcription-polymerase chain reaction (RT-PCR) using isolated RNA. Our results demonstrated that taraxasterol has a strong stimulatory effect on osteoblastic cell proliferation/ enhancement, and on maintaining the phenotype. Taraxasterol also regulated osteoblast differentiation through the upregulation of ALP expression in rat osteoblastic cells. Also, treatment with taraxasterol enhanced the transcript levels of BMP-2, RUNX2, ALP, BSP, COL-I, and OCN. The underlying mechanism might be associated with taraxasterol's antioxidative effect, leading to favorable amounts of reactive oxygen species in the cellular environment. Thus, our study indicated that taraxasterol can be used as an osteogenic proliferation-enhancing agent for the therapy of osteoporosis.

Gamma-Tocotrienol Stimulates the Proliferation, Differentiation, and Mineralization in Osteoblastic MC3T3-E1 Cells

Γ-Tocotrienol Induced the Proliferation and Differentiation of MC3T3-E1 Cells Through the Stimulation of the Wnt/β-catenin Signaling Pathway.

Annatto-derived tocotrienol stimulates osteogenic activity in preosteoblastic MC3T3-E1 cells: a temporal sequential study

Tetrahydroxystilbene Glucoside Regulates Proliferation, Differentiation, and OPG/RANKL/M-CSF Expression in MC3T3-E1 Cells via the PI3K/Akt Pathway

Tigogenin inhibits adipocytic differentiation and induces osteoblastic differentiation in mouse bone marrow stromal cells

The biological effects of tocotrienol on bone: a review on evidence from rodent models

Taraxasterol As A Proliferation-Enhancing Agent To Enhance Osteogenic Differentiation Of Rat Osteoblastic Cells

Tectorigenin inhibits RANKL-induced osteoclastogenesis via suppression of NF-κB signalling and decreases bone loss in ovariectomized C57BL/6.

Tridax procumbens flavonoids promote osteoblast differentiation and bone formation

Inhibition of proliferation and induction of apoptosis by gamma-tocotrienol in human colon carcinoma HT-29 cells.

Effects Of Nano-Emulsion Preparations Of Tocopherols And Tocotrienols On Oxidative Stress And Osteoblast Differentiation

[The Effects of TGF-beta on the Proliferation and Differentiation of Human Osteoblast-Like Cells].

Protective effect of tetrahydroxystilbene glucoside against hydrogen peroxide-induced dysfunction and oxidative stress in osteoblastic MC3T3-E1 cells.

Tenuigenin promotes the osteogenic differentiation of bone mesenchymal stem cells in vitro and in vivo

Effects of 17Β-Estradiol and 1,25-Dihydroxyvitamin D3 on the Proliferation and Differentiation of Osteoblastic MC3T3-E1 Cells

The Effect of Triiodothyronine to Obsteoblast Proliferation of Rats

Positive Regulation of Osteoblast Proliferation and Differentiation in MC3T3- E1 Cells by 7,3',4'-Trimethoxyflavone

Influence of Oxytocin in Proliferation and Osteogenesis Activity of MG-63 Cells

Enhancing Effect of Vitexin on Osteogenic Activity of Murine Pre-Osteoblastic MC3T3-E1 Cells

Tussilagone inhibits osteoclastogenesis by modulating mitochondrial function and ROS production involved Nrf2 activation

Effect and mechanism of genistein on the proliferation of MC3T3-E1 cells